SEK 0.97
(-1.62%)
Year | Revenue | Revenue Growth |
---|---|---|
2023 | 4.44 Million SEK | -65.28% |
2022 | 12.78 Million SEK | 36.99% |
2021 | 9.33 Million SEK | 3741.56% |
2020 | 243 Thousand SEK | -75.82% |
2019 | 1 Million SEK | -5.72% |
2018 | 1.06 Million SEK | -28.93% |
2017 | 1.5 Million SEK | 1751.85% |
2016 | 81 Thousand SEK | 0.0% |
Year | Revenue | Revenue Growth |
---|---|---|
2024 Q1 | 1.47 Million SEK | 2319.67% |
2024 Q2 | 159 Thousand SEK | -89.23% |
2023 Q2 | 1.35 Million SEK | 6072.73% |
2023 FY | 4.44 Million SEK | -65.28% |
2023 Q1 | 22 Thousand SEK | 122.92% |
2023 Q4 | 61 Thousand SEK | -97.97% |
2023 Q3 | 2.99 Million SEK | 120.77% |
2022 FY | 12.78 Million SEK | 36.99% |
2022 Q4 | -96 Thousand SEK | -103.35% |
2022 Q3 | 2.86 Million SEK | -30.41% |
2022 Q2 | 4.12 Million SEK | -28.95% |
2022 Q1 | 5.8 Million SEK | 48.99% |
2021 Q2 | 4.32 Million SEK | 107900.0% |
2021 FY | 9.33 Million SEK | 3741.56% |
2021 Q3 | 1.12 Million SEK | -74.03% |
2021 Q4 | 3.89 Million SEK | 246.97% |
2021 Q1 | 4000.00 SEK | -99.1% |
2020 FY | 243 Thousand SEK | -75.82% |
2020 Q4 | 446 Thousand SEK | 406.82% |
2020 Q2 | 65 Thousand SEK | -63.48% |
2020 Q3 | 88 Thousand SEK | 35.38% |
2020 Q1 | 178 Thousand SEK | 1086.67% |
2019 Q2 | 537 Thousand SEK | 26.06% |
2019 FY | 1 Million SEK | -5.72% |
2019 Q4 | 15 Thousand SEK | -44.44% |
2019 Q3 | 27 Thousand SEK | -94.97% |
2019 Q1 | 426 Thousand SEK | 34.81% |
2018 Q2 | 250 Thousand SEK | 0.0% |
2018 Q3 | 250 Thousand SEK | 0.0% |
2018 Q1 | 250 Thousand SEK | -83.33% |
2018 Q4 | 316 Thousand SEK | 26.4% |
2018 FY | 1.06 Million SEK | -28.93% |
2017 FY | 1.5 Million SEK | 1751.85% |
2017 Q2 | - SEK | 0.0% |
2017 Q3 | - SEK | 0.0% |
2017 Q4 | 1.5 Million SEK | 0.0% |
2017 Q1 | - SEK | 0.0% |
2016 FY | 81 Thousand SEK | 0.0% |
Name | Revenue | Revenue Difference |
---|---|---|
AddLife AB (publ) | 9.68 Billion SEK | 99.954% |
Biotage AB (publ) | 1.86 Billion SEK | 99.762% |
Bonesupport Holding AB (publ) | 591.07 Million SEK | 99.249% |
Doxa AB (publ) | 9.9 Million SEK | 55.152% |
Elekta AB (publ) | 18.11 Billion SEK | 99.975% |
iZafe Group AB (publ) | 1.82 Million SEK | -143.688% |
Ortivus AB (publ) | 84.08 Million SEK | 94.719% |
Ortivus AB (publ) | 84.08 Million SEK | 94.719% |
S2Medical AB (publ) | 6.97 Million SEK | 36.311% |
Synsam AB (publ) | 5.9 Billion SEK | 99.925% |